Venous Thromboembolism
Conference Coverage
Pregnancy in rheumatic disease quadruples risk of cardiovascular events
Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than...
Latest News
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indications
Of the 35 trials studied, most involved patients with atopic dermatitis.
From the Journals
Supplemental oxygen fails to improve echocardiographic measures in PE patients
The proportions of patients with normalized RV/LV ratios were similar with and without supplemental oxygen.
Conference Coverage
Longer edoxaban may benefit cancer patients with distal DVT
“This is the first and only randomized trial to show the superiority of longer duration over shorter duration of anticoagulation therapy for...
Feature
Factor XI inhibitors: The promise of a truly safe anticoagulant?
The efficacy data in the phase 3 trials will be key to the success of these drugs. “That is a very important part of the puzzle that is still...
Latest News
Steady VKA therapy beats switch to NOAC in frail AFib patients: FRAIL-AF
The switch resulted in more bleeding without any reduction in thromboembolic complications or all-cause mortality.
Latest News
Medicare announces 10 drugs targeted for price cuts in 2026
People on Medicare may in 2026 see prices drop for 10 medicines, including pricey diabetes, cancer, blood clot, and arthritis treatments.
Opinion
American Geriatrics Society 2023 updated Beers Criteria highlights
The guidelines address safe prescribing of medications to older adults after review of 1,500 clinical trials and research studies.
From the Journals
Pulmonary embolism confers higher mortality long term
The most frequent causes of death were cancer, pulmonary embolism, infections, and cardiovascular events.
Latest News
Indefinite anticoagulation likely not cost effective after unprovoked VTE
Pros, cons, and lack of cost-effectiveness warrant shared decision-making based on preferences and values.
From the Journals
Rehabilitation improves walk test results for post–pulmonary embolism patients with persistent dyspnea
In patients with persistent dyspnea following a pulmonary embolism, rehabilitation should be considered as a treatment option.